Sincrolab
Sincrolab is a pioneering company dedicated to advancing mental health through innovative digital therapeutics and neuropsychological solutions. With a mission to democratize access to cutting-edge neurociencia and neurorehabilitation, it develops AI-driven, personalized, and effective tools for patients of all ages. Sincrolab collaborates with healthcare professionals, researchers, and institutions to deliver validated treatments, cognitive training, and assessment tools that are remote, flexible, and tailored to individual profiles. Its vision is to lead the future of neuropsicología, integrating science, technology, and social impact to improve lives worldwide.
Industries
Nr. of Employees
small (1-50)
Sincrolab
Products
Prescription digital therapeutic for attention disorders
A prescription-only software medical device delivered via mobile/tablet that uses gamified cognitive training and AI personalization to improve attention and inhibitory control in children, intended for clinician prescription and supervision.
Cloud-based clinician platform (dashboard and automated reports)
A professional web platform providing clinician dashboards, patient profiles, longitudinal performance views and automated compliance and outcome reporting.
CBT-based digital programs for anxiety and depression
Digital therapy programs based on cognitive behavioral therapy principles, intended to complement clinical care and be used in blended or remote models for mood disorders.
Prescription digital therapeutic for attention disorders
A prescription-only software medical device delivered via mobile/tablet that uses gamified cognitive training and AI personalization to improve attention and inhibitory control in children, intended for clinician prescription and supervision.
Cloud-based clinician platform (dashboard and automated reports)
A professional web platform providing clinician dashboards, patient profiles, longitudinal performance views and automated compliance and outcome reporting.
CBT-based digital programs for anxiety and depression
Digital therapy programs based on cognitive behavioral therapy principles, intended to complement clinical care and be used in blended or remote models for mood disorders.
Services
Design and operational support for randomized controlled trials and clinical studies to evaluate digital therapeutic efficacy and publish results.
Remote webinars, on-demand tutorials and implementation resources to train clinicians on platform features, intervention protocols and report interpretation.
Delivery of structured remote cognitive training programs with scheduled neuropsychological assessments and clinician-configured platform adjustments.
Partnerships with academic groups and advisory board members to design studies, analyze neurophysiological data and co-author publications.
Production of audio and webinar content aimed at clinicians and the public to disseminate evidence, guidance and product information.
Design and operational support for randomized controlled trials and clinical studies to evaluate digital therapeutic efficacy and publish results.
Remote webinars, on-demand tutorials and implementation resources to train clinicians on platform features, intervention protocols and report interpretation.
Delivery of structured remote cognitive training programs with scheduled neuropsychological assessments and clinician-configured platform adjustments.
Partnerships with academic groups and advisory board members to design studies, analyze neurophysiological data and co-author publications.
Production of audio and webinar content aimed at clinicians and the public to disseminate evidence, guidance and product information.
Expertise Areas
- Prescription digital therapeutics (SaaMD) development
- Clinical trial management and evidence generation for digital interventions
- AI-driven personalized cognitive training
- CBT-based digital program development for mood disorders
Key Technologies
- AI-driven adaptive algorithms
- Gamified cognitive training
- Mobile and tablet application delivery
- Cloud-based clinician dashboards and reporting
News & Updates
Sincrolab becomes the first in Spain to receive CE Class IIa certification for a digital mental health treatment combining AI and video games, approved for medical prescription.
Details about the certification, clinical validation, and the impact on mental health treatment in Spain.
Digital Therapeutics in Mental Health: The Future is Now
An overview of how validated digital therapeutics are transforming mental health treatment, with examples from Sincrolab's innovations.
The Impact of AI and Video Games in Treating ADHD
A detailed look at Sincrolab's Sea of Heroes: New World and its clinical validation.
Regulatory Milestones in Digital Mental Health
The significance of CE Class IIa certification for digital treatments in Spain and Europe.
First digital mental health treatment in Spain with CE Class IIa, combining AI and video games, approved for prescription.
Sincrolab becomes the first in Spain to receive CE Class IIa certification for a digital mental health treatment combining AI and video games, approved for medical prescription.
Details about the certification, clinical validation, and the impact on mental health treatment in Spain.
Digital Therapeutics in Mental Health: The Future is Now
An overview of how validated digital therapeutics are transforming mental health treatment, with examples from Sincrolab's innovations.
The Impact of AI and Video Games in Treating ADHD
A detailed look at Sincrolab's Sea of Heroes: New World and its clinical validation.
Regulatory Milestones in Digital Mental Health
The significance of CE Class IIa certification for digital treatments in Spain and Europe.
First digital mental health treatment in Spain with CE Class IIa, combining AI and video games, approved for prescription.